This one splits a room. Where legitimate medicine ends and a trend running ahead of the data begins, and who in here is actually doing something about it. We're working to bring in a couple of outside voices, more on that as it's confirmed.

This month's conversation sits at the intersection of medicine and performance, an area more of the room is already exploring personally, professionally, or both. About ten minutes of reading below.

Testosterone replacement therapy restores testosterone in men (and sometimes women) with clinically low levels, delivered by injection, gel, patch, or pellet. What's changed is who's pursuing it: a growing share of men in their 30s and 40s are now testing and treating low T through direct-to-consumer telehealth clinics rather than a primary care visit. The open question in the field is where legitimate treatment for diagnosed deficiency ends and a performance trend running ahead of the long-term data begins.

Peptides are short chains of amino acids that signal the body toward a specific effect: tissue repair (BPC-157), metabolic effects (GLP-1 compounds like semaglutide), or growth hormone release (secretagogues). The ground is moving under this one in real time. In July 2026, an FDA advisory panel voted to allow six peptides, BPC-157 among them, back onto the approved compounding list. That vote isn't binding, formal rulemaking could take until 2028, and the FDA's own scientists flagged that human safety data is still thin. Compounded GLP-1s remain legal only during official drug shortages, not as a general alternative to the branded versions.

Concierge longevity medicine, comprehensive biomarker panels, imaging, and ongoing coaching sold as a membership rather than a visit, is one of the fastest-growing categories in healthcare. It sits at the same intersection as the other two topics: a genuine medical service and a business model at once, which is a large part of why it's ended up on this table.

This one tends to split a room: some see legitimate medicine, others see a trend running ahead of the data, and plenty of you have an opinion formed from personal experience. Come ready for an open conversation, not a lecture. Worth thinking about beforehand: what are you actually doing in this space, if anything, and why.

What's happening in your world that this room should know about.